Canopy Growth (TSE:WEED) Reaches New 1-Year Low – What’s Next?

Posted by Francis Steltz on Oct 10th, 2026

Canopy Growth Corp (TSE:WEED – Get Free Report) shares reached a new 52-week low on Thursday. The stock traded as low as C$1.17 and last traded at C$1.19, with a volume of 746,527 shares traded. The stock had previously closed at C$1.26.

Analysts Set New Price Targets

Separately, Alliance Global Partners cut their target price on Canopy Growth from C$1.80 to C$1.60 in a research report on Tuesday, June 16th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of C$1.88.

Read Our Latest Stock Analysis on WEED

Canopy Growth Stock Down 2.5%

The company has a quick ratio of 2.32, a current ratio of 3.04 and a debt-to-equity ratio of 40.27. The firm has a market capitalization of C$499.18 million, a PE ratio of -1.76, a price-to-earnings-growth ratio of -0.01 and a beta of 2.41. The business’s 50-day moving average price is C$1.34 and its 200-day moving average price is C$1.39.

Canopy Growth (TSE:WEED – Get Free Report) last released its quarterly earnings data on Friday, August 7th. The company reported C($0.03) earnings per share for the quarter. Canopy Growth had a negative net margin of 73.95% and a negative return on equity of 29.85%. The company had revenue of C$81.17 million during the quarter. As a group, equities research analysts predict that Canopy Growth Corp will post -0.69 EPS for the current fiscal year.

Insider Activity at Canopy Growth

In other news, Director David Angelo Lazzarato sold 22,380 shares of the firm’s stock in a transaction on Monday, September 28th. The shares were sold at an average price of C$1.29, for a total transaction of C$28,870.20. Following the transaction, the director owned 108,237 shares in the company, valued at approximately C$139,625.73. This trade represents a 17.13% decrease in their position. In the last quarter, insiders have sold 43,492 shares of company stock worth $56,105. Corporate insiders own 0.21% of the company’s stock.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.